INOVIO and GeneOne Life Science Report Positive Phase 1/2a Cli...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 29, 2020 /PRNewswire-AsiaNet/ -- - INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV- INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTR...
Authors: LATEST ASIANET NEWS RELEASES